Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP)

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by:
UMC Utrecht
ClinicalTrials.gov Identifier:
NCT00150904
First received: September 6, 2005
Last updated: February 13, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)